OPKO HEALTH, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $606.9M | $713.1M | $863.5M | $1.0B | $1.8B |
| Gross profit | $205.9M | $218.5M | $318.1M | $288.2M | — |
| Operating income | -$117.4M | -$152.1M | -$157.0M | -$226.3M | $18.8M |
| Operating expenses | — | — | $1.0B | $1.2B | $1.8B |
| Cost of revenue | $400.9M | $494.6M | $545.4M | $716.0M | — |
| Cash from operations | -$178.5M | -$183.5M | -$28.2M | -$95.2M | $38.3M |
| Capital expenditure | $12.3M | $25.0M | $16.3M | $24.6M | $32.2M |
| Free cash flow | -$190.8M | -$208.5M | -$44.5M | -$119.8M | $6.2M |
| Share repurchases | $47.0M | $90.2M | $0 | $0 | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $1.9B | $2.2B | $2.0B | $2.2B | $2.4B |
| Total liabilities | $664.0M | $834.8M | $622.5M | $605.6M | $714.6M |
Shares outstanding 755.1M
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.